337 related articles for article (PubMed ID: 24189377)
1. D-Cycloserine lowers kynurenic acid formation--new mechanism of action.
Baran H; Kepplinger B
Eur Neuropsychopharmacol; 2014 Apr; 24(4):639-44. PubMed ID: 24189377
[TBL] [Abstract][Full Text] [Related]
2. Increased kynurenic acid levels and decreased brain kynurenine aminotransferase I in patients with Down syndrome.
Baran H; Cairns N; Lubec B; Lubec G
Life Sci; 1996; 58(21):1891-9. PubMed ID: 8637415
[TBL] [Abstract][Full Text] [Related]
3. Cerebrolysin lowers kynurenic acid formation--an in vitro study.
Baran H; Kepplinger B
Eur Neuropsychopharmacol; 2009 Mar; 19(3):161-8. PubMed ID: 19008081
[TBL] [Abstract][Full Text] [Related]
4. Dual effect of DL-homocysteine and S-adenosylhomocysteine on brain synthesis of the glutamate receptor antagonist, kynurenic acid.
Luchowska E; Luchowski P; Paczek R; Ziembowicz A; Kocki T; Turski WA; Wielosz M; Lazarewicz J; Urbanska EM
J Neurosci Res; 2005 Feb; 79(3):375-82. PubMed ID: 15605380
[TBL] [Abstract][Full Text] [Related]
5. Kynurenine Aminotransferases I, II and III Are Present in Saliva.
Baran H; Kronsteiner C; Kepplinger B
Neurosignals; 2020 Mar; 28(1):1-13. PubMed ID: 32153151
[TBL] [Abstract][Full Text] [Related]
6. Kynurenic acid metabolism in the brain of HIV-1 infected patients.
Baran H; Hainfellner JA; Kepplinger B; Mazal PR; Schmid H; Budka H
J Neural Transm (Vienna); 2000; 107(10):1127-38. PubMed ID: 11129102
[TBL] [Abstract][Full Text] [Related]
7. Oral administration of a specific kynurenic acid synthesis (KAT II) inhibitor attenuates evoked glutamate release in rat prefrontal cortex.
Bortz DM; Wu HQ; Schwarcz R; Bruno JP
Neuropharmacology; 2017 Jul; 121():69-78. PubMed ID: 28419874
[TBL] [Abstract][Full Text] [Related]
8. Astrocytic localization of kynurenine aminotransferase II in the rat brain visualized by immunocytochemistry.
Guidetti P; Hoffman GE; Melendez-Ferro M; Albuquerque EX; Schwarcz R
Glia; 2007 Jan; 55(1):78-92. PubMed ID: 17024659
[TBL] [Abstract][Full Text] [Related]
9. Kynurenic acid and kynurenine aminotransferase in heart.
Baran H; Amann G; Lubec B; Lubec G
Pediatr Res; 1997 Mar; 41(3):404-10. PubMed ID: 9078543
[TBL] [Abstract][Full Text] [Related]
10. A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats.
Koshy Cherian A; Gritton H; Johnson DE; Young D; Kozak R; Sarter M
Neuropharmacology; 2014 Jul; 82():41-8. PubMed ID: 24647121
[TBL] [Abstract][Full Text] [Related]
11. Demonstration of kynurenine aminotransferases I and II and characterization of kynurenic acid synthesis in cultured cerebral cortical neurons.
Rzeski W; Kocki T; Dybel A; Wejksza K; Zdzisińska B; Kandefer-Szerszeń M; Turski WA; Okuno E; Albrecht J
J Neurosci Res; 2005 Jun; 80(5):677-82. PubMed ID: 15880762
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme inhibitors modulate kynurenic acid production in rat brain cortex in vitro.
Zakrocka I; Turski WA; Kocki T
Eur J Pharmacol; 2016 Oct; 789():308-312. PubMed ID: 27423316
[TBL] [Abstract][Full Text] [Related]
13. Kynurenine metabolism in Alzheimer's disease.
Baran H; Jellinger K; Deecke L
J Neural Transm (Vienna); 1999; 106(2):165-81. PubMed ID: 10226937
[TBL] [Abstract][Full Text] [Related]
14. Dysfunction of brain kynurenic acid metabolism in Huntington's disease: focus on kynurenine aminotransferases.
Jauch D; Urbańska EM; Guidetti P; Bird ED; Vonsattel JP; Whetsell WO; Schwarcz R
J Neurol Sci; 1995 May; 130(1):39-47. PubMed ID: 7650530
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II type 1 receptor blockers decrease kynurenic acid production in rat kidney in vitro.
Zakrocka I; Targowska-Duda KM; Wnorowski A; Kocki T; Jóźwiak K; Turski WA
Naunyn Schmiedebergs Arch Pharmacol; 2019 Feb; 392(2):209-217. PubMed ID: 30370429
[TBL] [Abstract][Full Text] [Related]
16. Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain?
Wu HQ; Rassoulpour A; Schwarcz R
J Neural Transm (Vienna); 2007 Jan; 114(1):33-41. PubMed ID: 16932989
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial aspartate aminotransferase: a third kynurenate-producing enzyme in the mammalian brain.
Guidetti P; Amori L; Sapko MT; Okuno E; Schwarcz R
J Neurochem; 2007 Jul; 102(1):103-11. PubMed ID: 17442055
[TBL] [Abstract][Full Text] [Related]
18. Effects of COX-1 and COX-2 inhibitors on the firing of rat midbrain dopaminergic neurons--possible involvement of endogenous kynurenic acid.
Schwieler L; Erhardt S; Nilsson L; Linderholm K; Engberg G
Synapse; 2006 Apr; 59(5):290-8. PubMed ID: 16416446
[TBL] [Abstract][Full Text] [Related]
19. Kynurenic Acid Levels and Kynurenine Aminotransferase I, II and III Activities in Ganglia, Heart and Liver of Snail Helix Pomatia.
Kronsteiner C; Baran H; Kepplinger B
Cell Physiol Biochem; 2023 Aug; 57(4):279-297. PubMed ID: 37597169
[TBL] [Abstract][Full Text] [Related]
20. beta-adrenergic enhancement of brain kynurenic acid production mediated via cAMP-related protein kinase A signaling.
Luchowska E; Kloc R; Olajossy B; Wnuk S; Wielosz M; Owe-Larsson B; Urbanska EM
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):519-29. PubMed ID: 19439240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
